The Food and Drug Administration granted de novo approval to Modius Spero, marking it the world’s first neuromodulation device authorized to treat symptoms associated with post-traumatic stress disorder. The wearable device was developed by Neurovalens and uses low-level electrical stimulation…
The Latest
EMS revenue doesn’t start with a claim. It starts the moment a crew responds to a call. Patient care report narratives, level-of-service determinations and mileage entries all shape whether a claim is strong or vulnerable before it ever reaches a…
Presented by:
- Steve Loures
The Department of Veterans Affairs is launching a clinical trial evaluating methylenedioxymethamphetamine-assisted therapy, or MDMA-assisted therapy, for veterans with post-traumatic stress disorder and alcohol use disorder. The trial will enroll approximately 80 veterans, comparing outcomes between participants receiving MDMA-assisted therapy…
Transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM) affects far more patients than most health systems realize — and the data show many are going undiagnosed and unmanaged.1-7 Recent Becker’s Healthcare and Alnylam survey research, with perspectives from more than 100 health system leaders,…
Presented by:
- Ginger Biesbrock, DSc, PA-C, MPH, FACC
- Nitasha Sarswat, MD
- Joshua S. Weber, PharmD, MBA-HCM, CSP, DPLA, 340B ACE
The expiration of COVID-19-era eviction moratoriums was associated with increases in psychotropic medication prescriptions and outpatient visits for serious mental illness, according to a study published May 22 in JAMA Health Forum. Researchers from Baltimore-based Johns Hopkins Bloomberg School of…
The U.S. had 14,024 mental health treatment facilities in 2024, including inpatient, residential and outpatient centers, according to KFF. Outpatient facilities accounted for the largest share, with 11,966 locations nationwide, while 2,447 facilities provided 24-hour residential care and 1,278 offered…
Nonprofit organizations continued to operate the majority of U.S. mental health treatment facilities in 2024, though for-profit ownership gained ground compared to 2022, according to KFF. KFF examined data from the 2024 National Substance Use and Mental Health Services survey…
Patient charts are dense, prior authorization workflows are fragmented and documentation demands continue to pull clinician time away from care. For healthcare leaders, these aren’t emerging concerns — they’re operational realities with measurable consequences. This on-demand executive conversation examines how…
On Demand
Presented by:
- Preeti Grewal
- Jesse Cugliotta
- Dr. Paige Kilian, MD
Preference-sensitive surgeries — like spine fusions, hip replacements and cataract surgeries — represent a significant and often underestimated source of payer medical spend. Yet most health plans have no clear line of sight into this category. Because these procedures cut…
Presented by:
- Cathy Hartman
- Nicola Merryman
One-fourth of children treated at autism therapy clinics spend nearly eight hours a day in therapy, according to a recent investigation by The New York Times. Here are five things to know:
